Although VEGF is widely recognized as an ideal target for regulating angiogenesis therapies [29, 30], recent evidence has suggested that SDF-1 is a key player in ischemic retinopathies, such as proliferative retinopathy and retinopathy of prematurity [31]. The gene discussed is VEGFA; the disease is retinal disorder.